A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006)
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effectiveness, safety and tolerability of a range
of doses of MK-1602 versus placebo in the treatment of acute migraine.